Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Linezolid in the treatment of multidrug-resistant tuberculosis.

Schecter GF, Scott C, True L, Raftery A, Flood J, Mase S.

Clin Infect Dis. 2010 Jan 1;50(1):49-55. doi: 10.1086/648675.

2.

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.

Sotgiu G, Centis R, D'Ambrosio L, Alffenaar JW, Anger HA, Caminero JA, Castiglia P, De Lorenzo S, Ferrara G, Koh WJ, Schecter GF, Shim TS, Singla R, Skrahina A, Spanevello A, Udwadia ZF, Villar M, Zampogna E, Zellweger JP, Zumla A, Migliori GB.

Eur Respir J. 2012 Dec;40(6):1430-42. doi: 10.1183/09031936.00022912. Epub 2012 Apr 10. Review.

3.

Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis.

Cox H, Ford N.

Int J Tuberc Lung Dis. 2012 Apr;16(4):447-54. doi: 10.5588/ijtld.11.0451. Review.

PMID:
22325685
4.

Linezolid for the treatment of patients with [corrected] mycobacterial infections [corrected] a systematic review.

Ntziora F, Falagas ME.

Int J Tuberc Lung Dis. 2007 Jun;11(6):606-11. Review. Erratum in: Int J Tuberc Lung Dis. 2007 Aug;11(8):936.

PMID:
17519090
5.

[The analysis of clinical data about the treatment of linezolid against tuberculosis].

Nie WJ, Chu NH.

Zhonghua Jie He He Hu Xi Za Zhi. 2013 Aug;36(8):601-3. Review. Chinese. No abstract available.

PMID:
24252739
6.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
7.

WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis.

Chang KC, Yew WW, Tam CM, Leung CC.

Antimicrob Agents Chemother. 2013 Sep;57(9):4097-104. doi: 10.1128/AAC.00120-13. Epub 2013 Jun 17. Review.

8.

Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations.

Garcia-Prats AJ, Rose PC, Hesseling AC, Schaaf HS.

Tuberculosis (Edinb). 2014 Mar;94(2):93-104. doi: 10.1016/j.tube.2013.10.003. Epub 2013 Oct 27. Review.

PMID:
24388605
9.

Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation.

Abate G.

Ethiop Med J. 2002 Jan;40(1):79-86. Review.

PMID:
12240570
10.

Drug treatment of multidrug-resistant osteoarticular tuberculosis: a systematic literature review.

Suárez-García I, Noguerado A.

Int J Infect Dis. 2012 Nov;16(11):e774-8. doi: 10.1016/j.ijid.2012.07.011. Epub 2012 Aug 30. Review.

11.

Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability.

Kwon YS, Jeong BH, Koh WJ.

Expert Opin Pharmacother. 2015 Feb;16(2):253-61. doi: 10.1517/14656566.2015.973853. Epub 2014 Oct 18. Review.

PMID:
25327169
12.

Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis.

van der Werf MJ, Langendam MW, Huitric E, Manissero D.

Eur Respir J. 2012 Jun;39(6):1511-9. doi: 10.1183/09031936.00125711. Epub 2011 Oct 17. Review.

13.

Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.

Chahine EB, Karaoui LR, Mansour H.

Ann Pharmacother. 2014 Jan;48(1):107-15. doi: 10.1177/1060028013504087. Epub 2013 Nov 1. Review.

PMID:
24259600
14.

Pulmonary resection for patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.

Xu HB, Jiang RH, Li L.

J Antimicrob Chemother. 2011 Aug;66(8):1687-95. doi: 10.1093/jac/dkr210. Epub 2011 Jun 3. Review.

15.

Synthetic investigational new drugs for the treatment of tuberculosis.

Kwon YS, Koh WJ.

Expert Opin Investig Drugs. 2016;25(2):183-93. doi: 10.1517/13543784.2016.1121993. Epub 2015 Dec 14. Review.

PMID:
26576631
16.

Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.

Blair HA, Scott LJ.

Drugs. 2015 Jan;75(1):91-100. doi: 10.1007/s40265-014-0331-4. Review.

PMID:
25404020
17.

Tuberculosis: clinical trials and new drug regimens.

Kwon YS, Jeong BH, Koh WJ.

Curr Opin Pulm Med. 2014 May;20(3):280-6. doi: 10.1097/MCP.0000000000000045. Review.

PMID:
24614239
18.

Bedaquiline for the treatment of pulmonary, multidrug-resistant tuberculosis in adults.

Gras J.

Drugs Today (Barc). 2013 Jun;49(6):353-61. doi: 10.1358/dot.2013.49.6.1970865. Review.

PMID:
23807939
19.

Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment.

Winters N, Butler-Laporte G, Menzies D.

Eur Respir J. 2015 Nov;46(5):1461-70. doi: 10.1183/13993003.00649-2015. Epub 2015 Sep 17. Review.

PMID:
26381514
20.

TMC207 becomes bedaquiline, a new anti-TB drug.

Palomino JC, Martin A.

Future Microbiol. 2013 Sep;8(9):1071-80. doi: 10.2217/fmb.13.85. Review.

PMID:
24020736
Items per page

Supplemental Content

Write to the Help Desk